Ursodeoxycholic Acid 300 mg / 450 mg SR Tablets
Indicated for Chronic Cholestatic Liver Disease
Therapeutic Benefits:
- Cytoprotective effect of UDCA reduces oxidative stress in hepatocytes
- Reduces elevated liver enzymes (ALT & AST)
- Lowers total bilirubin levels
- Decreases concentration of toxic bile acids
- Drug of choice in the treatment of Primary Biliary Cholangitis (PBC)
Indications:
- Primary Biliary Cholangitis (PBC)
- Chronic Cholestatic Liver Disease
- Hypercholesterolemia
- Intrahepatic Cholestasis of Pregnancy
